A widely anticipated report about clinical trial oversight at the University of Minnesota found that its institutional ethics committee lacks expertise to review study protocols and its policies must be upgraded to protect study participants. Moreover, the report also cited a “culture of fear” in the university psychiatry department, which first triggered concerns about clinical trial practices.

“The university’s efforts with regard to human subjects protections do not consistently reflect ‘best practices’ and are not, at...